C(OC(=O)[NH:7][C:8]1[CH:13]=[CH:12][C:11]([C:14]#[C:15][C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)=[CH:10][C:9]=1[NH2:22])(C)(C)C.[Cl:24][C:25]1[CH:26]=[C:27]([C:31]2OC(C)(C)O[C:33](=[O:39])[CH:32]=2)[CH:28]=[CH:29][CH:30]=1.C(O)(C(F)(F)F)=O>C(Cl)Cl>[Cl:24][C:25]1[CH:26]=[C:27]([C:31]2[CH2:32][C:33](=[O:39])[NH:22][C:9]3[CH:10]=[C:11]([C:14]#[C:15][C:16]4[CH:17]=[CH:18][CH:19]=[CH:20][CH:21]=4)[CH:12]=[CH:13][C:8]=3[N:7]=2)[CH:28]=[CH:29][CH:30]=1Prepared from (2-amino-4-phenylethynyl-phenyl)-carbamic acid tert.-butyl ester (Example G2) and 6-(3-chloro-phenyl)-2,2-dimethyl-[1,3]dioxin-4-one (Example J6) according to the general procedure K. The obtained material was deprotected and cyclized by treatment with TFA in CH2Cl2 according to the general procedure M. Obtained as an orange solid (155 mg).
読み込み中…